96P PAM50-based ROR indexes as a tool to individualize the use of neoadjuvant endocrine therapy in ER+/HER2- breast cancer
Lopez Velazco, J.I., Manzano, S., Elorriaga, K., Lahuerta Martinez, A., Álvarez, L.A., Etxabe Azkue, I., Huarte Martinez, M., Buch, E., Giménez Climent, J., Quiroga Garcia, V., Aragón, S., Paré, L., Prat, A., Alvarez Lopez, I., Muñoz Caffarel, M., Urruticoechea, A.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article